by Richard Daverman, PhD
November 26, 2013 -- Lee’s Pharmaceutical Holdings, a China drugmaker, has found a partner to market its topical short-term anesthesia product in the US. Marathon Pharmaceuticals signed a 10-year exclusive US licensing agreement for Zingo® (lidocaine hydrochloride monohydrate) powder intradermal injection system. Zingo, with an onset of action of just one to three minutes, is used to allay the pain of a needlestick procedure. Usually, Lee’s is in the news for in-licensing products from the west; Zingo is its first product to be taken back to the US. More details....
Stock Symbol: (HK: 950)
Help employers find you! Check out all the jobs and post your resume.
